
Virgin Media O2 plans sweeping savings and substantial workforce reductions. The telecommunications company is targeting £800m in annual cost savings by 2029, with changes to staffing, fibre investment, procurement and business operations.

Midlands food business Hangry Moose has changed its ownership structure. Darren Smith and Alex Moran plan additional locations and commercial partnerships alongside investment in menu development and operations.

Peak-season campaigns demand landing pages that work across international markets. Weglot’s Eugene Ernoult outlines how localisation, multilingual SEO, and consistent updates can support campaign performance.

The Organic Pharmacy has returned to founder Margo Marrone’s ownership. Companies House confirms the transfer of control from Istituto Ganassini, with plans to expand professional wellness activities.

WPP’s media business recovered while creative services continued to decline. Third-quarter like-for-like revenue less pass-through costs fell 2.1%, with the company maintaining full-year guidance.

Online retail growth outpaced store sales across Britain in October. BDO recorded 10.1% online growth against 2.2% in stores, with discretionary sales rising 4.6% overall.

The Bank reports changing hiring patterns as businesses adopt AI. Its latest business intelligence identifies reduced trainee recruitment, evolving professional services pricing, and increased technology expenditure.

New workplace rules strengthen employers’ obligations to prevent unlawful harassment. Legislation now requires all reasonable steps against sexual harassment and introduces protections covering customers, clients, and other third parties.

Aston Martin’s quarterly revenue increased as Valhalla deliveries strengthened results. Sales rose 36% to £388.7m and the pre-tax loss narrowed to £77.1m, although overall wholesale volumes were largely unchanged and net debt remained substantial at £1.57bn.

GSK’s specialty medicines sales increased despite weaker demand for vaccines. Specialty revenue rose 15% to £3.9bn, supported by HIV, respiratory and oncology treatments. Core operating profit increased 5% at constant exchange rates, while statutory operating profit declined.